Progyny PGNY 深 沪
已收盘 10-16 16:00:00 美东时间
26.86
-0.595
-2.17%
华盛通- 最 高27.78
- 今 开27.65
- 成交量 91.96万股
- 最 低 26.74
- 昨 收 27.455
- 总市值 20.61亿
- 52周最高 33.065
- 市盈率 静 41.25
- 换手率 1.20%
- 52周最低 16.10
- 委 比 -16.32%
- 总股本 7672.68万
- 历史最高 68.32
- 量 比 1.04
- 振 幅 3.79%
- 历史最低 13.29
- 每 手 1
- 风险率 4.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Progyny收跌2.17%，成交额2492.51万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
今天 05:27
Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market Dynamics
Progyny expects to add 1.2 million new covered lives by mid-2027, reflecting employers' growing reliance on proven solutions to manage medical cost inflation and improve ROI. Progyny's fertility and women's health solutions address critical workforce needs while driving savings and clinical outcomes.
10-07 12:28
BofA identifies Russell 2000 stocks positioned for Fed hiking cycles
BofA Research has identified a group of Russell 2000 stocks rated Buy or Neutral that rank well on factors that have historically outperformed during periods of Federal Reserve interest-rate hikes. Th...
09-23 23:26
美股大行评级 | 多家大行齐上调Robinhood目标价！最高看至150美元；安进股价大跌后评级遭下调
今日重点评级关注：Chardan Capital：维持Hyperion DeFi"买入"评级，目标价从7.3美元升至8.45美元；摩根大通：维持Vera Therapeutics"超配"评级，目标价从76美元升至83美元
09-09 15:36
Citizens Maintains Market Outperform on Progyny, Raises Price Target to $33
Citizens analyst Constantine Davides maintains Progyny (NASDAQ:PGNY) with a Market Outperform and raises the price target from $31 to $33.
09-08 21:36
Progyny, Inc. to Present at the Wells Fargo Healthcare Conference
Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, announced that its Chief Financial Officer, Mark Livingston, will present at the Wells Fargo 21st Annual Healthcare Conference in Boston on September 8, 2026, at 11:00 a.m. ET. A live audiocast and replay will be available on Progyny’s investor relations website. Progyny empowers patients with comprehensive support, access to specialists, and tools to i...
09-03 15:16
美股大行评级 | 塔吉特获13家大行上调目标价；Moderna携手默沙东齐获大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Ultragenyx Pharmaceutical"超配"评级，目标价从96美元升至103美元；Canaccord Genuity：维持Ultragenyx Pharmaceutical"买入"评级，目标价从81美元升至83美元
08-21 11:40
Wells Fargo Initiates Coverage On Progyny with Overweight Rating, Announces Price Target of $37
Wells Fargo analyst Stan Berenshteyn initiates coverage on Progyny (NASDAQ:PGNY) with a Overweight rating and announces Price Target of $37.
08-20 22:08
美股大行评级 | 潜在涨幅544.53%！Scynexis获古根海姆升目标价至33美元，维持"买入"评级
今日重点评级关注：古根海姆：维持Scynexis"买入"评级，目标价从24美元升至33美元；韦德布什：维持Kura Oncology"跑赢大市"评级，目标价从36美元升至38美元
08-14 11:51
美股大行评级 | 业绩大超预期！ CoreWeave、超微电脑、Lumentum绩后获多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从49美元升至56美元；韦德布什：维持Zura Bio"跑赢大市"评级，目标价从15美元升至22美元
08-13 11:44
